OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
9
Results
Show all
Save search
Copy query
Show results for
Unknown
(9)
Publication Date
Release Date
2025
(4)
2024
(2)
2023
(1)
2021
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications.
Not available
S-EPMC7923321
|
biostudies-literature
Cite
National Cancer Grid of India Consensus Guidelines on the Management of Cervical Cancer.
Not available
S-EPMC6223405
|
biostudies-literature
Cite
Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort.
Not available
S-EPMC9975378
|
biostudies-literature
Cite
First-line pembrolizumab for metastatic NSCLC in lower-middle-income countries: bridging the efficacy-effectiveness gap.
Not available
S-EPMC12427484
|
biostudies-literature
Cite
A Decade of Treating ALK-Rearranged Non-Small Cell Lung Cancer in a Lower Middle-Income Country: Changing Patterns and Improving Survival.
Not available
S-EPMC12647493
|
biostudies-literature
Cite
Evaluating the Appropriate Use Criteria for Coronary Revascularization in Stable Ischemic Heart Disease Using Randomized Data From the ISCHEMIA Trial.
Not available
S-EPMC11919559
|
biostudies-literature
Cite
Health Status Outcomes With Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in ISCHEMIA.
Not available
S-EPMC12492304
|
biostudies-literature
Cite
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Not available
S-EPMC11658795
|
biostudies-literature
Cite
Factors Associated With Coronary Angiography Performed Within 6 Months of Randomization to the Conservative Strategy in the ISCHEMIA Trial.
Not available
S-EPMC11187765
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets